FDA PMA
FDA Class 3
30-Day Notice Accepted
🇺🇸 United States
Hepatitis Viral B Dna Detection
PMA: P080026
·
Supplement: S009
·
Decision Aug 20, 2013
Classifications
1
FEI Numbers
8
Registration Numbers
8
Basic Information
- Device Name
- Hepatitis Viral B Dna Detection
- Trade Name
- ABBOTT REALTIME HBV
- PMA Number
- P080026
- Supplement Number
- S009
- Device Class
- FDA Class 3
- Product Code
- MKT
- Generic Name
- Hepatitis Viral B DNA Detection
- Medical Specialty
- Unknown
- Advisory Committee
- Microbiology
- Decision
- 30-Day Notice Accepted
- Decision Code
- OK30
- Decision Date
- August 20, 2013
- Date Received
- July 23, 2013
- Supplement Type
- 30-Day Notice
- Expedited Review
- N
Advisory Committee Statement
CHANGE TO THE MANUFACTURING PROCESS FOR OLIGONUCLEOTIDES AND THE ADDITION OF TWO NEW SUPPLIERS FOR A RAW MATERIAL.
Classifications
This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| MKT | Hepatitis Viral B Dna Detection | FDA class 3 | Unknown |